Biotech

All Articles

Pfizer, Valneva show lyme ailment go successful for 2nd enhancer

.Pfizer and also Valneva may possess regarding two even more years to wait just before they make the...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's study a talk with Ayla Ellison, Fierce Biotech Managing Editor and also Michelle Benz as th...

New data demonstrate how Bayer's asundexian fell short to avoid strokes

.Bayer put on hold the period 3 trial for its variable XIa prevention asundexian late last year afte...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its a number of sclerosis (MS) med tolebrutinib to the FD...

Galapagos' stockpile as fund reveals intent to mold its own progression

.Galapagos is actually happening under added pressure coming from real estate investors. Having actu...

Cell- concentrated Sana scoops first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and also ...

Allist pays off Jacobio $21M, landing function in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually bought itself a starring character in China's KRAS mar...

ReNeuron leaving purpose substitution after missing out on fundraising objective

.ReNeuron has actually joined the lengthy checklist of biotechs to leave Greater london's purpose se...

MBX apply for IPO to take opposition to Ascendis right into stage 3

.MBX Biosciences has contributed to the latest spurt of IPO filings. The biotech, which submitted it...

FDA broadens probe into Lykos' MDMA trials: WSJ

.For Lykos Rehabs and the provider's would-be MDMA-assisted treatment for trauma (PTSD), the favorit...